A GUIDE TO UNDERSTANDING & SUPPORT

Iridocorneal endothelial (ICE) syndrome

ICE is a rare acquired disorder linking the cornea, iris and fluid-drainage angle. This guide explains its related forms and why corneal clarity and pressure-related nerve protection often need coordinated care.

Abnormal corneal cells can affect the iris and drainage angle, causing edema and secondary glaucoma.

Sources checked 24 Oct 2026Clinical review pendingEditorial sources
Explore the visual example
Report new pain or rapid visual change Seek urgent eye assessment for sudden visual reduction, a painful red eye or halos accompanied by substantial pain or illness. Do not assume these are routine ICE symptoms. After glaucoma or corneal surgery, follow the service’s specific emergency return instructions. [2] [6]
EXPERIENCE, THEN EXPLAIN

Explore the visual exampleVisual example

VisualSim illustration

Adjust selected symptom features for discussion. Read the limits beside the controls. [1] [3]

A limited example of selected symptoms. It cannot identify this condition. [1] [3]

An example is already enabled. Adjust the controls to describe your experience.

Original clinic illustration. The interactive symptom example loads when graphics are available.
OriginalIllustrative view

Adjust this symptom example4 relevant settings
Relevant illustration controls

Blur

20

Halos around lights

18
40

Glare / photophobia

12

Haze and glare can illustrate selected corneal-edema symptoms. They do not simulate glaucoma damage, pupil optics, ICE-cell behavior or the experience of every person.

01 / THE QUICK EXPLANATION

Understanding Iridocorneal endothelial (ICE) syndrome

ICE syndrome includes Chandler syndrome, progressive iris atrophy and Cogan–Reese syndrome. They share abnormal behavior of corneal endothelial cells but differ in the prominence of corneal, iris and pressure-related changes. The condition is usually more evident in one eye and is generally acquired rather than a straightforward inherited dystrophy. [2] [3]

Its important consequences are not only a changed pupil. Corneal edema can reduce optical clarity, while impaired fluid outflow can cause glaucoma and irreversible optic-nerve injury. A clear cornea or improved pressure at one visit does not remove the need to monitor the other components. [1] [3]

02 / WHAT PEOPLE MAY EXPERIENCE

One condition. Different experiences.

Original VisualSim schematic illustrations, informed by the cited clinical descriptions. These are not study figures, patient recordings or validated severity levels.

Blur, glare or halos

Corneal edema can scatter light and reduce clarity. Symptoms may fluctuate, and an example of haze cannot show how much endothelial function remains or establish the cause. [2] [3]

A changed iris or pupil

The pupil may become displaced or irregular and the iris may develop thinning or nodules depending on the form. Visible change is a clinical clue, not a measure of visual ability. [1] [3]

Pressure-related damage may be unnoticed

Glaucoma can affect the optic nerve and visual field without a matching level of discomfort. Regular pressure, nerve and field assessment matters even if a person feels the eye is doing well. [3] [6]

One process can affect three structures

Original schematic of linked structures; no diagnostic or prognostic function. [1] [3]

Original VisualSim teaching diagram · © VisualSim. Clinical basis in linked sources; not a published study figure. Image provenance.
  1. Cornea

    Abnormal endothelium may allow edema and reduced clarity.

  2. Iris and angle

    Cell migration and membrane contraction can distort tissue and drainage.

  3. Optic nerve

    Raised pressure may lead to secondary glaucoma requiring separate surveillance.

03 / WHAT WE KNOW

What is happening—and what remains uncertain

Abnormal endothelial cells can migrate across the drainage angle and iris. A membrane and adhesions may interfere with fluid leaving the eye and distort the iris. Endothelial dysfunction also compromises corneal fluid regulation, allowing swelling. [1] [2]

The initiating cause remains incompletely understood. Proposed viral and cellular mechanisms are research hypotheses rather than proof that everyone needs antiviral treatment. Current management largely addresses complications; it does not reliably eliminate the underlying abnormal cell behavior. [3] [7]

04 / MAKING DISTINCTIONS

What can look similar?

Fuchs endothelial dystrophy

Both can cause endothelial failure and edema, but Fuchs is a different disease with different inheritance and angle/iris findings. A Fuchs surgical result is not automatically an ICE outcome. [3] [7]

Developmental anterior-segment disorders

Conditions present from development can also involve iris abnormalities and glaucoma. Age of onset, laterality and examination help distinguish them from acquired ICE. [7]

Primary glaucoma

In ICE, abnormal anterior-segment tissue contributes to a secondary outflow problem. Pressure control and the choice of surgery must account for the cornea, angle and progression of adhesions. [3] [4]

Similar-looking symptoms can have different causes. A matching picture cannot establish a diagnosis.

05 / GETTING AN ASSESSMENT

What an assessment may involve

  1. Look beyond the visible pupilSlit-lamp examination and gonioscopy assess the cornea, iris, angle and adhesions. Selected endothelial imaging or anterior-segment imaging may help identify characteristic cell and structural changes. [3] [7]
  2. Measure separate threats to sightPressure measurement, optic-nerve imaging and visual fields assess glaucoma, while corneal evaluation addresses edema and clarity. These investigations answer different questions and should not be substituted for one another. [3] [4]
  3. Review the whole surgical historyPrevious grafts, cataract surgery or glaucoma devices affect the next decision. Ask whether cornea and glaucoma specialists should plan together, including how one procedure could influence the other tissues. [4] [5]
06 / CARE AND UNCERTAINTY

What may help—and what is still being studied

Control pressure and monitor the nerve

Medicines may be used, and filtering or drainage-device surgery may be required when control is insufficient. Repeat intervention can be necessary. The aim is preserving remaining nerve function, not reversing established glaucomatous loss. [2] [4]

Treat visually significant endothelial failure

Corneal transplantation can improve clarity in selected eyes. The choice between full-thickness or endothelial grafting depends on anatomy, pressure control, prior operations and specialist experience, with graft failure or later procedures possible. [2] [5]

Keep realistic expectations about comparisons

Available ICE surgical evidence is largely small and nonrandomized. A favorable pressure or graft outcome in a series does not establish that one operation is best for every eye or that both complications have been solved permanently. [4] [5]

07 / DAILY LIFE

What this can mean for daily life

Keep separate symptom and follow-up goals

Record glare, clarity and discomfort alongside the appointments for pressure, nerve and field monitoring. A less cloudy scene is useful, but not proof that glaucoma is stable. [3]

Make the prescribed regimen manageable

Tell the team about side effects, cost or difficulty using drops. Ask which medicine serves pressure control and which serves the corneal surface or postoperative plan; do not stop or exchange them independently. [4] [6]

Plan for procedures with written instructions

Ask about positioning, protection, travel, drops and review dates for the operation actually planned. Previous glaucoma devices and corneal grafts make individualized aftercare especially important. [4] [5]

Use broader support for each practical need

Glaucoma UK can support living with pressure-related disease, while sight-loss services can help with accessibility. No active dedicated ICE charity was verified; broader services should be described honestly rather than advertised as ICE specialists. [6] [8]

08 / YOUR NEXT CONVERSATION

Bring a clearer description to your appointment

Choose the questions you want to discuss. These choices stay in this page’s memory.

09 / LOOK CLOSER

Research, with the context left in

Selected studies and guidance, with their populations and limitations. These are curated educational summaries, not a complete systematic review or a formal evidence rating.

2026 · Clinical review with literature search.

Contemporary ICE review

Integrates the disease spectrum, multimodal diagnosis and management of secondary glaucoma and endothelial failure. [3]

Limits and applicability: A narrative synthesis includes hypotheses and small surgical literature; it does not establish a disease-modifying cure.

2024 · Retrospective comparative series of 29 eyes, 13 undergoing trabeculectomy and 16 a valve procedure.

Trabeculectomy and Ahmed valve outcomes

Both approaches reduced pressure over two years; complete success without medication was less frequent than combined success definitions. [4]

Limits and applicability: Nonrandom selection, small groups and limited duration prevent a reliable superiority claim. Pressure thresholds, medication use and repeat operations change what success means.

2025 · Nineteen studies, with aggregate and individual-patient analyses comparing graft approaches; search through April 2024.

Keratoplasty in ICE systematic review

Reported visual improvement across approaches and differences in graft survival that warrant further study. [5]

Limits and applicability: Underlying observational studies, surgical selection and differing follow-up constrain comparisons. No significant difference is not proof that prior glaucoma surgery has no effect in an individual eye.

Questions researchers still need to answer
  • Which biological process initiates ICE, and can it be safely modified before glaucoma or edema develops?
  • How should glaucoma and corneal procedures be sequenced to maximize durable sight and minimize repeat surgery?
  • Which standardized outcomes best capture clarity, visual field, treatment burden and graft survival together?
10 / KEEP LEARNING

Trusted places to go next

Selected clinical references, research, practical support and ways to connect. Official pages checked 24 October 2026; each entry explains its scope and region.

Clinical education · US public education

National Eye Institute corneal-disease information

Contains an accessible ICE section explaining iris changes, corneal swelling and glaucoma.

Clinical education · US specialty organization; education internationally

AAO ICE patient guide

Current patient overview of the linked corneal and pressure problems.

Charity & support · UK support services; public information internationally

Glaucoma UK

Helpline, education, buddy support and group information for the glaucoma component of ICE. Not a dedicated ICE diagnostic service.

Connections listed by the organization.

Access & practical help · US rare-disease information; education internationally

GARD ICE information

Rare-disease orientation and information-navigation routes. A research link is not a guarantee of an active recruiting study.

11 / COMMON QUESTIONS

Questions you may still have

Are Chandler and Cogan–Reese different from ICE?

They are clinical forms within the ICE spectrum, alongside progressive iris atrophy. The most prominent tissue changes can differ. [3]

Does it always affect both eyes?

ICE is usually clinically unilateral or strongly asymmetric, unlike many inherited corneal dystrophies. The specialist still examines both eyes and considers alternative diagnoses. [3] [7]

Will clearing the cornea fix glaucoma?

Not necessarily. Corneal clarity and pressure-related optic-nerve protection are different goals that often need separate monitoring and treatment. [3] [4] [5]

Is there a single best surgery?

The evidence does not establish one universal choice. Anatomy, prior surgery, pressure control and the main cause of reduced sight guide the plan. [4] [5]

12 / TRANSPARENCY

Sources, image credits and review status

Compiled by VisualSim from clinical references and published research. Sources checked 24 October 2026. Independent clinical review has not been recorded; no named clinical reviewer or clinical validation is claimed. Research evidence and its limitations are linked below.

  1. National Eye Institute: Other Types of Corneal Disease, ICE section (n.d.; institution).

    Relevant page content and scope checked; source verification is not independent clinical review.

    Checked 2026-10-24 · Public page checked
  2. AAO: What Is Iridocorneal Endothelial Syndrome? (2026; institution).

    Current original indexed patient content read; direct client403.

    Checked 2026-10-24 · Public page checked
  3. Iridocorneal endothelial syndrome: contemporary review (2026; review).

    Relevant page content and scope checked; source verification is not independent clinical review.

    Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed
  4. Outcomes of Trabeculectomy and Ahmed Glaucoma Valve Implantation in ICE (2024; observational).

    Relevant page content and scope checked; source verification is not independent clinical review.

    Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed
  5. Outcomes of Penetrating Keratoplasty Versus Lamellar Endothelial Keratoplasty in ICE: systematic review (2025; systematic review).

    Author-university repository abstract and publication metadata checked; original DOI 10.1016/j.ajo.2025.04.017. PubMed direct client footer-only.

    Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed
  6. Glaucoma UK: further help and information (n.d.; institution).

    Relevant page content and scope checked; source verification is not independent clinical review.

    Checked 2026-10-24 · Public page checked
  7. Iridocorneal Endothelial Syndrome, StatPearls (2023; review).

    Indexed clinical overview read; actual content update 2023, not assumed 2026 from book-series header.

    Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed
  8. RNIB: practical sight-loss support (n.d.; institution).

    Relevant page content and scope checked; source verification is not independent clinical review.

    Checked 2026-10-24 · Public page checked

The simulator helps people communicate an experience. It cannot diagnose a condition, measure a visual field, or establish that someone is safe to drive.

Enlarged figure